210 related articles for article (PubMed ID: 21959034)
1. Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus.
Dolff S; Abdulahad WH; Westra J; Doornbos-van der Meer B; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2011; 13(5):R157. PubMed ID: 21959034
[TBL] [Abstract][Full Text] [Related]
2. AhR-ROR-γt complex is a therapeutic target for MAP4K3/GLK
Chuang HC; Chen YM; Chen MH; Hung WT; Yang HY; Tseng YH; Tan TH
FASEB J; 2019 Oct; 33(10):11469-11480. PubMed ID: 31318609
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
4. IL-22 production of effector CD4
Dolff S; Scharpenberg C; Specker C; Kribben A; Witzke O; Wilde B
Eur J Med Res; 2019 Jul; 24(1):24. PubMed ID: 31331400
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.
Dolff S; Quandt D; Wilde B; Feldkamp T; Hua F; Cai X; Specker C; Kribben A; Kallenberg CG; Witzke O
Arthritis Res Ther; 2010; 12(4):R150. PubMed ID: 20653937
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus.
Terrier B; Costedoat-Chalumeau N; Garrido M; Geri G; Rosenzwajg M; Musset L; Klatzmann D; Saadoun D; Cacoub P
J Rheumatol; 2012 Sep; 39(9):1819-28. PubMed ID: 22859347
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
[TBL] [Abstract][Full Text] [Related]
9. Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients.
Qin WZ; Chen LL; Pan HF; Leng RX; Zhai ZM; Wang C; Li RJ; Wang S; Wang HP; Ye DQ
Clin Exp Med; 2011 Dec; 11(4):245-50. PubMed ID: 21487830
[TBL] [Abstract][Full Text] [Related]
10. Increased IL-17 and IL-21 producing TCRαβ+CD4-CD8- T cells in Chinese systemic lupus erythematosus patients.
Wang HX; Chu S; Li J; Lai WN; Wang HX; Wu XJ; Kang X; Qiu YR
Lupus; 2014 Jun; 23(7):643-54. PubMed ID: 24554709
[TBL] [Abstract][Full Text] [Related]
11. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.
Yang J; Chu Y; Yang X; Gao D; Zhu L; Yang X; Wan L; Li M
Arthritis Rheum; 2009 May; 60(5):1472-83. PubMed ID: 19404966
[TBL] [Abstract][Full Text] [Related]
12. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
13. Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus.
Dolff S; Bijl M; Huitema MG; Limburg PC; Kallenberg CG; Abdulahad WH
Clin Immunol; 2011 Nov; 141(2):197-204. PubMed ID: 21920821
[TBL] [Abstract][Full Text] [Related]
14. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
[TBL] [Abstract][Full Text] [Related]
15. Decreased interleukin 35 and CD4+EBI3+ T cells in patients with active systemic lupus erythematosus.
Ouyang H; Shi YB; Liu ZC; Wang Z; Feng S; Kong SM; Lu Y
Am J Med Sci; 2014 Aug; 348(2):156-61. PubMed ID: 25054737
[TBL] [Abstract][Full Text] [Related]
16. Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Puwipirom H; Hirankarn N; Sodsai P; Avihingsanon Y; Wongpiyabovorn J; Palaga T
Arthritis Res Ther; 2010; 12(6):R215. PubMed ID: 21110900
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of PU.1 in CD4
Xiang N; Fang X; Sun XG; Zhou YB; Ma Y; Zhu C; Li XP; Wang GS; Tao JH; Li XM
Clin Exp Med; 2021 Nov; 21(4):621-632. PubMed ID: 33966135
[TBL] [Abstract][Full Text] [Related]
18. Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.
Sippl N; Faustini F; Rönnelid J; Turcinov S; Chemin K; Gunnarsson I; Malmström V
Clin Exp Immunol; 2021 Jul; 205(1):44-52. PubMed ID: 33576004
[TBL] [Abstract][Full Text] [Related]
19. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.
Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453
[TBL] [Abstract][Full Text] [Related]
20. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
Lin J; Yue LH; Chen WQ
Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
